[
  {
    "objectID": "LICENSE.html",
    "href": "LICENSE.html",
    "title": "cSVD burden project",
    "section": "",
    "text": "Attribution 4.0 International\n=======================================================================\nCreative Commons Corporation (‚ÄúCreative Commons‚Äù) is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an ‚Äúas-is‚Äù basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.\nUsing Creative Commons Public Licenses\nCreative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.\n Considerations for licensors: Our public licenses are\n intended for use by those authorized to give the public\n permission to use material in ways otherwise restricted by\n copyright and certain other rights. Our licenses are\n irrevocable. Licensors should read and understand the terms\n and conditions of the license they choose before applying it.\n Licensors should also secure all rights necessary before\n applying our licenses so that the public can reuse the\n material as expected. Licensors should clearly mark any\n material not subject to the license. This includes other CC-\n licensed material, or material used under an exception or\n limitation to copyright. More considerations for licensors:\nwiki.creativecommons.org/Considerations_for_licensors\n\n Considerations for the public: By using one of our public\n licenses, a licensor grants the public permission to use the\n licensed material under specified terms and conditions. If\n the licensor's permission is not necessary for any reason--for\n example, because of any applicable exception or limitation to\n copyright--then that use is not regulated by the license. Our\n licenses grant only permissions under copyright and certain\n other rights that a licensor has authority to grant. Use of\n the licensed material may still be restricted for other\n reasons, including because others have copyright or other\n rights in the material. A licensor may make special requests,\n such as asking that all changes be marked or described.\n Although not required by our licenses, you are encouraged to\n respect those requests where reasonable. More considerations\n for the public: \nwiki.creativecommons.org/Considerations_for_licensees\n=======================================================================\nCreative Commons Attribution 4.0 International Public License\nBy exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution 4.0 International Public License (‚ÄúPublic License‚Äù). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.\nSection 1 ‚Äì Definitions.\n\nAdapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.\nAdapter‚Äôs License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.\nCopyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.\nEffective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.\nExceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.\nLicensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.\nLicensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.\nLicensor means the individual(s) or entity(ies) granting rights under this Public License.\nShare means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.\nSui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.\nYou means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.\n\nSection 2 ‚Äì Scope.\n\nLicense grant.\n\nSubject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:\n\nreproduce and Share the Licensed Material, in whole or in part; and\nproduce, reproduce, and Share Adapted Material.\n\nExceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.\nTerm. The term of this Public License is specified in Section 6(a).\nMedia and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)\n\nnever produces Adapted Material.\n\nDownstream recipients.\n\nOffer from the Licensor ‚Äì Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.\nNo downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.\n\nNo endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).\n\nOther rights.\n\nMoral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.\nPatent and trademark rights are not licensed under this Public License.\nTo the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.\n\n\nSection 3 ‚Äì License Conditions.\nYour exercise of the Licensed Rights is expressly made subject to the following conditions.\n\nAttribution.\n\nIf You Share the Licensed Material (including in modified form), You must:\n\nretain the following if it is supplied by the Licensor with the Licensed Material:\n\nidentification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);\na copyright notice;\na notice that refers to this Public License;\na notice that refers to the disclaimer of warranties;\na URI or hyperlink to the Licensed Material to the extent reasonably practicable;\n\nindicate if You modified the Licensed Material and retain an indication of any previous modifications; and\nindicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.\n\nYou may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.\nIf requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.\nIf You Share Adapted Material You produce, the Adapter‚Äôs License You apply must not prevent recipients of the Adapted Material from complying with this Public License.\n\n\nSection 4 ‚Äì Sui Generis Database Rights.\nWhere the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:\n\nfor the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database;\nif You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and\nYou must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.\n\nFor the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.\nSection 5 ‚Äì Disclaimer of Warranties and Limitation of Liability.\n\nUNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.\nTO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.\nThe disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.\n\nSection 6 ‚Äì Term and Termination.\n\nThis Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.\nWhere Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:\n\nautomatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or\nupon express reinstatement by the Licensor.\n\nFor the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.\nFor the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.\nSections 1, 5, 6, 7, and 8 survive termination of this Public License.\n\nSection 7 ‚Äì Other Terms and Conditions.\n\nThe Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.\nAny arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.\n\nSection 8 ‚Äì Interpretation.\n\nFor the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.\nTo the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.\nNo term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.\nNothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.\n\n=======================================================================\nCreative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the ‚ÄúLicensor.‚Äù The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark ‚ÄúCreative Commons‚Äù or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.\nCreative Commons may be contacted at creativecommons.org."
  },
  {
    "objectID": "doc/svd-score.html",
    "href": "doc/svd-score.html",
    "title": "SVD score tool",
    "section": "",
    "text": "Primary: continuous scale for grading SVD burden, for possible use in current as well as historical data.\nSecondary: risk stratification of new stroke, dementia; correlation to life style factors.\n\n\n\n\n\n\nOnly intended for research use currently\n\n\n\nThe following scoring system is not formally published and has not been through peer-review."
  },
  {
    "objectID": "doc/svd-score.html#purpose",
    "href": "doc/svd-score.html#purpose",
    "title": "SVD score tool",
    "section": "",
    "text": "Primary: continuous scale for grading SVD burden, for possible use in current as well as historical data.\nSecondary: risk stratification of new stroke, dementia; correlation to life style factors.\n\n\n\n\n\n\nOnly intended for research use currently\n\n\n\nThe following scoring system is not formally published and has not been through peer-review."
  },
  {
    "objectID": "doc/svd-score.html#sec-scorr",
    "href": "doc/svd-score.html#sec-scorr",
    "title": "SVD score tool",
    "section": "Scoring table",
    "text": "Scoring table\n\nSVD score table\n\n\n\n\n\n\n\nMRI features\nRaw score\nShort score\n\n\n\n\nNumber of microbleeds (T2*/SWI)\n\n\n\n\n0\n0\n0\n\n\n1\n1\n1\n\n\n2-4\n2\n1\n\n\n5-10\n3\n1\n\n\n&gt;10\n4\n1\n\n\nLocation of microbleeds ‚Äì no points (T2*/SWI)\n\n\n\n\nLobar, deep, or infratentorial (choose one or more)\nL/D/I\n-\n\n\nSuperficiel siderose (T2*/SWI)\n\n\n\n\nNo siderosis\n0\n-\n\n\n1 sulcus\n1\n-\n\n\n&gt;1 sulcus\n2\n-\n\n\nLacunes (FLAIR)\n\n\n\n\n0\n0\n0\n\n\n1\n1\n1\n\n\n2\n2\n1\n\n\n3-5\n3\n1\n\n\n&gt;5\n4\n1\n\n\nWhite matter hyperintensities ‚Äì see Figure 1 (FLAIR)\n\n\n\n\nAbsent\n0\n0\n\n\nPunctate foci\n1\n0\n\n\nBeginning confluence\n2\n1\n\n\nLarge confluent areas\n3\n1\n\n\nAtrophy - see Figure 2 (FLAIR/T1)\n\n\n\n\nNo\n0\n0\n\n\nMild\n1\n0\n\n\nModerate\n2\n1\n\n\nSevere\n3\n1\n\n\nTotal SVD score\n0-16\n0-4"
  },
  {
    "objectID": "doc/svd-score.html#setting",
    "href": "doc/svd-score.html#setting",
    "title": "SVD score tool",
    "section": "Setting",
    "text": "Setting\nThe scoring system is intended for use with acute MRI stroke scans. Scans are performed according to the acute stroke protocol at the given time of scan. Available sequences are DWI, ADC, 2D FLAIR, and T2* or SWI in our setting, but if available 3D FLAIR and T1 sequences should be used. Data capturing should reflect this, if data is later merged from different populations.\nScoring is performed independently by trained neurologists. Inter-rate-reliability-measures are performed to ensure validity.\n\nDifferent suggested scores\nInspired by the scores from"
  },
  {
    "objectID": "doc/svd-score.html#definitions-on-bio-markers",
    "href": "doc/svd-score.html#definitions-on-bio-markers",
    "title": "SVD score tool",
    "section": "Definitions on bio-markers",
    "text": "Definitions on bio-markers\nDefinitions are mainly according to the STRIVE v1 criteria,(Joanna M. Wardlaw et al. 2013) with minor local specifications. The bio-markers included are within the suggestions from Markus et al. (2022) in the FINESSE framework.\n\nMicrobleeds\nSequence: T2*/SWI\nSmall (generally 2‚Äì5 mm in diameter, but sometimes up to 10 mm) areas of signal void with associated blooming seen on SWI-weighted MRI.\nDifferent cut-offs are used in different trials.(Akoudad et al. 2016) We try to register in a way, so that our analysis can be made similarly to other studies and to provide enough resolution.\nAs discussions about the importance of location is ongoing,(Vernooij et al. 2008) we register if microbleeds are located lobar, deep, or infratentorial.\n\n\nSuperficial siderosis\nSequence: T2*/SWI\n‚ÄúInvestigators should describe the location of siderosis (i.e., the number of sulci involved and in which lobes).‚Äù(Joanna M. Wardlaw et al. 2013, 828)\n\n\nLacunar infarcts\nSequence: 2D/3D FLAIR\n‚ÄúA round or ovoid, subcortical, fluid-filled cavity (signal similar to CSF) of between 3 mm and about 15 mm in diameter, consistent with a previous acute small subcortical infarct or haemorrhage in the territory of one perforating arteriole.‚Äù(Joanna M. Wardlaw et al. 2013, 825)\nAdditionally: ‚ÄúWe identified asymptomatic lacunar infarcts as sharply demarcated hyperintense lesions &lt;20 mm on T2-weighted images with corresponding hypointense lesions with a hyperintense rim on FLAIR. In lacunar stroke patients, the lesion could not be compatible with the clinical stroke.‚Äù(Huijts et al. 2013)\nBased on the practice by Olama et al. (2020) and the 2021 ESO guidelines on covert small vessel disease, lacunes are counted 0, 1 , 2 , 3-5 and &gt;5.(Joanna M. Wardlaw et al. 2021)\n\n\nWhite matter hyperintensities\nSequence: 2D/3D FLAIR\nThe Fazekas subscale for deep white matter is used. The scale divides the white matter in periventricular and deep white matter, and each region is given a grade depending on the size and confluence of lesions.(Fazekas et al. 1987)\nNo regional differences is noted.(Groot et al. 2000) Scoring is performed with visual reference from Radiopedia.org.\n\n\nAtrophy\nSequence: 2D/3D FLAIR or T1\nWe follow definitions for the Global Cerebral Atrophy (GCA) score.(Harper et al. 2015)\nA picture sample for reference is used.(Harper et al. 2015, fig. 1)"
  },
  {
    "objectID": "doc/svd-score.html#references",
    "href": "doc/svd-score.html#references",
    "title": "SVD score tool",
    "section": "References",
    "text": "References\n\n\nAkoudad, Saloua, Frank J. Wolters, Anand Viswanathan, Ren√©e F. de Bruijn, Aad van der Lugt, Albert Hofman, Peter J. Koudstaal, M. Arfan Ikram, and Meike W. Vernooij. 2016. ‚ÄúAssociation of Cerebral Microbleeds With Cognitive Decline and Dementia.‚Äù JAMA neurology 73 (8): 934‚Äì43. https://doi.org/10.1001/jamaneurol.2016.1017.\n\n\nFazekas, F, JB Chawluk, A Alavi, HI Hurtig, and RA Zimmerman. 1987. ‚ÄúMR Signal Abnormalities at 1.5 T in Alzheimer‚Äôs Dementia and Normal Aging.‚Äù American Journal of Roentgenology 149 (2): 351‚Äì56. https://doi.org/10.2214/ajr.149.2.351.\n\n\nGroot, J. C. de, F. E. de Leeuw, M. Oudkerk, J. van Gijn, A. Hofman, J. Jolles, and M. M. Breteler. 2000. ‚ÄúCerebral white matter lesions and cognitive function: the Rotterdam Scan Study.‚Äù Annals of Neurology 47 (2): 145‚Äì51. https://doi.org/10.1002/1531-8249(200002)47:2&lt;145::aid-ana3&gt;3.3.co;2-g.\n\n\nHarper, Lorna, Frederik Barkhof, Nick C. Fox, and Jonathan M. Schott. 2015. ‚ÄúUsing Visual Rating to Diagnose Dementia: A Critical Evaluation of MRI Atrophy Scales.‚Äù Journal of Neurology, Neurosurgery & Psychiatry 86 (11): 1225‚Äì33. https://doi.org/10.1136/jnnp-2014-310090.\n\n\nHuijts, Marjolein, Annelien Duits, Robert J. van Oostenbrugge, Abraham A. Kroon, Peter W. de Leeuw, and Julie Staals. 2013. ‚ÄúAccumulation of MRI Markers of Cerebral Small Vessel Disease is Associated with Decreased Cognitive Function. A Study in First-Ever Lacunar Stroke and Hypertensive Patients.‚Äù Frontiers in Aging Neuroscience 5: 72. https://doi.org/10.3389/fnagi.2013.00072.\n\n\nMarkus, Hugh S., Wiesje M. van Der Flier, Eric E. Smith, Philip Bath, Geert Jan Biessels, Emily Briceno, Amy Brodtman, et al. 2022. ‚ÄúFramework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE).‚Äù JAMA Neurology 79 (11): 1187. https://doi.org/10.1001/jamaneurol.2022.2262.\n\n\nOlama, Ali Amin Al, James M. S. Wason, Anil M. Tuladhar, Esther M. C. van Leijsen, Marisa Koini, Edith Hofer, Robin G. Morris, Reinhold Schmidt, Frank-Erik de Leeuw, and Hugh S. Markus. 2020. ‚ÄúSimple MRI Score Aids Prediction of Dementia in Cerebral Small Vessel Disease.‚Äù Neurology 94 (12): e1294‚Äì1302. https://doi.org/10.1212/WNL.0000000000009141.\n\n\nVernooij, M. W., A. van der Lugt, M. A. Ikram, P. A. Wielopolski, W. J. Niessen, A. Hofman, G. P. Krestin, and M. M. B. Breteler. 2008. ‚ÄúPrevalence and Risk Factors of Cerebral Microbleeds: The Rotterdam Scan Study.‚Äù Neurology 70 (14): 1208‚Äì14. https://doi.org/10.1212/01.wnl.0000307750.41970.d9.\n\n\nWardlaw, Joanna M, Stephanie Debette, Hanna Jokinen, Frank-Erik De Leeuw, Leonardo Pantoni, Hugues Chabriat, Julie Staals, et al. 2021. ‚ÄúESO Guideline on Covert Cerebral Small Vessel Disease.‚Äù European Stroke Journal 6 (2): CXI‚ÄìCLXII. https://doi.org/10.1177/23969873211012132.\n\n\nWardlaw, Joanna M., Eric E. Smith, Geert J. Biessels, Charlotte Cordonnier, Franz Fazekas, Richard Frayne, Richard I. Lindley, et al. 2013. ‚ÄúNeuroimaging Standards for Research into Small Vessel Disease and Its Contribution to Ageing and Neurodegeneration.‚Äù The Lancet Neurology 12 (8): 822‚Äì38. https://doi.org/10.1016/S1474-4422(13)70124-8."
  },
  {
    "objectID": "doc/down-to-work.html",
    "href": "doc/down-to-work.html",
    "title": "Allocation and workflow",
    "section": "",
    "text": "Assessor allocation of subject IDs\n\n\nassessor\nIDs\n\n\n\n\nall\nsvd_1-65\n\n\nAGD\nsvd_66-150"
  },
  {
    "objectID": "doc/down-to-work.html#sec-allocations",
    "href": "doc/down-to-work.html#sec-allocations",
    "title": "Allocation and workflow",
    "section": "",
    "text": "Assessor allocation of subject IDs\n\n\nassessor\nIDs\n\n\n\n\nall\nsvd_1-65\n\n\nAGD\nsvd_66-150"
  },
  {
    "objectID": "doc/down-to-work.html#sec-suggested-workflow",
    "href": "doc/down-to-work.html#sec-suggested-workflow",
    "title": "Allocation and workflow",
    "section": "Suggested workflow",
    "text": "Suggested workflow\nIn REDCap:\n\nLogin to AU REDCap, open the ‚ÄúSVD-burden POOL‚Äù project and go to ‚ÄúRecord Status Dashboard‚Äù (just follow this link)\nFrom the drop-down ‚ÄúDashboard displayed‚Äù, choose the desired dashboard (there is one common for the first, and one for each assessor with allocated subjects and progress).\nOpen the ‚ÄúSVD score‚Äù instrument to start capturing the score.\n\nIf the ‚Äúdot‚Äù is colored, the instrument already has been filled. Press the ‚Äú+‚Äù-sign to create a new version (mainly necessary during the inter-rater-reliability testing, as each subject is only scored once)\n\nIn the top of the instrument, the patient CPR, name and admission time is printed as well as assessor allocated (should be you, but please check) and link to Citrix for convenience.\n\nIn Citrix/PACS:\n\nOpen the ‚ÄúBilleddiagnostik PACS‚Äù module (find it under ‚ÄúAPPS‚Äù and ‚Äústar‚Äù it the first time) and look up the patient using the CPR number copied from REDCap.\nPlease use the subject admission date and time as reference to select the correct scan and the exact date and time of the scan (fields are pre-filled with admission date and time).\nThe scan might take a minute or two to load from the storage server. A little patience is necessary. The first time, you can use this time to arrange your program windows for optimal workflow.\n\nMaximise the ‚ÄúPACS‚Äù window on the left half of yuor screen and ‚ÄúREDCap‚Äù on the left (to have controls line up in the middle and minimize cursor movement)\nNote that the REDCap is organized by MRI sequences (T2*/SWI and FLAIR) corresponding to how they are organized in PACS. The relevant sequences are usually found at the buttom of the list in PACS.\n\n\nIn REDCap:\n\nWhen done filling out all fields, you can save the data and go directly to the next subject by clicking ‚ÄúSave & Go To Next Record‚Äù\n\nThe last item is ‚ÄúComplete?‚Äù. Use ‚ÄúIncomplete‚Äù if interrupted, ‚ÄúUnverified‚Äù in case of doubt, ‚ÄúComplete‚Äù when completed.\nOn the right and at the end of the instrument, there are two blue boxes. The top is ‚ÄúSave & Exit Form‚Äù, the second have different options to choose from by clicking the arrow on the right. Choose ‚ÄúSave & Go To Next Record‚Äù. Then repeat step 3-8."
  },
  {
    "objectID": "doc/plan.html",
    "href": "doc/plan.html",
    "title": "Project plan",
    "section": "",
    "text": "SVD scoring scale locked after slight modifications after consensus decision within the assessor group.\nScoring introduction arranged\nEveryone scores the same initial 50 subjects. Inter-rater-reliability statistics are calculated on both the full scale and a shortened scale with a Cohens ùõã of respectively .7 and .8 as the goal before continued scoring. If measures are not satisfying group session with scoring examples will be repeated.\nAfter the first assessment relibility phase, each assessor will have a number of subjects allocated for scoring/annotation (see Allocations). Annotation can be performed on standard personal work station/computer (please ensure adequate lightning conditions) and at any time. You‚Äôll need access to Citrix and PACS (see Workflow for a suggested optimal workflow).\nDuring the scoring process I will be able to follow the progress and check-in with you to provide help if needed. And I‚Äôll make sure to create a few competitions along the way.\nWhen all participants are scored, I will be running analyses and send the draft manuscript for comments."
  },
  {
    "objectID": "doc/plan.html#project-plan",
    "href": "doc/plan.html#project-plan",
    "title": "Project plan",
    "section": "",
    "text": "SVD scoring scale locked after slight modifications after consensus decision within the assessor group.\nScoring introduction arranged\nEveryone scores the same initial 50 subjects. Inter-rater-reliability statistics are calculated on both the full scale and a shortened scale with a Cohens ùõã of respectively .7 and .8 as the goal before continued scoring. If measures are not satisfying group session with scoring examples will be repeated.\nAfter the first assessment relibility phase, each assessor will have a number of subjects allocated for scoring/annotation (see Allocations). Annotation can be performed on standard personal work station/computer (please ensure adequate lightning conditions) and at any time. You‚Äôll need access to Citrix and PACS (see Workflow for a suggested optimal workflow).\nDuring the scoring process I will be able to follow the progress and check-in with you to provide help if needed. And I‚Äôll make sure to create a few competitions along the way.\nWhen all participants are scored, I will be running analyses and send the draft manuscript for comments."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "SVD burden annotation project",
    "section": "",
    "text": "This page is intended as a reference manual for accessors as well as other collaborators in annotating and analysing a large pooled, clinical dataset of stroke patients from Aarhus University Hospital included in different research projects.\n\n\nSVD in the brain is still uncharted territory. We have two large datasets (possibly supplemented with additional projects) on acute stroke patients that we have the opportunity to merge and link with data from MRI scans. The first project is to investigate the relationship between various lifestyle factors and the degree of SVD among stroke patients. We also plan to use the data for other projects in the future.\n\n\n\nNo widely used scoring system exists, that considers all elements of SVD on MRI. The Fazekas score is widely used, but only accounts for white matter hyperintensities (WMH).\nBased on existing studies, we have developed a scoring tool for this purpose, relying on FLAIR and T2*/SWI sequences from the acute scans. We are interested in microbleeds, superficial siderosis, previous lacunar infarcts, white matter hyperintensities, and atrophy.\nWe have created a minimal registration tool in REDCap, that will later be enriched with metadata on the scans."
  },
  {
    "objectID": "index.html#about",
    "href": "index.html#about",
    "title": "SVD burden annotation project",
    "section": "",
    "text": "This page is intended as a reference manual for accessors as well as other collaborators in annotating and analysing a large pooled, clinical dataset of stroke patients from Aarhus University Hospital included in different research projects.\n\n\nSVD in the brain is still uncharted territory. We have two large datasets (possibly supplemented with additional projects) on acute stroke patients that we have the opportunity to merge and link with data from MRI scans. The first project is to investigate the relationship between various lifestyle factors and the degree of SVD among stroke patients. We also plan to use the data for other projects in the future.\n\n\n\nNo widely used scoring system exists, that considers all elements of SVD on MRI. The Fazekas score is widely used, but only accounts for white matter hyperintensities (WMH).\nBased on existing studies, we have developed a scoring tool for this purpose, relying on FLAIR and T2*/SWI sequences from the acute scans. We are interested in microbleeds, superficial siderosis, previous lacunar infarcts, white matter hyperintensities, and atrophy.\nWe have created a minimal registration tool in REDCap, that will later be enriched with metadata on the scans."
  },
  {
    "objectID": "Notes.html",
    "href": "Notes.html",
    "title": "cSVD burden project",
    "section": "",
    "text": "Notes:\n\nOvervej inklusion af simpel stroke klassifikation?\nbegrt√¶ns til alene at inkludere RESIST? Samt evt ENIGMA for validering?"
  },
  {
    "objectID": "doc/irr.html",
    "href": "doc/irr.html",
    "title": "Inter rater reliability",
    "section": "",
    "text": "Agreement is acceptable for all but atrophy. See calculations in the end.\nMy suggestion will be to re-plan. Instead of retraining, I will assign two assessors to each subject. On disagreement, consensus will be sought.\nWith 8 assessors helping out, each will get to perform a mean of ~250 assessments\n\nPros and cons to the new approach\n\n\n\n\n\n\nPros\nCons\n\n\n\n\nIncreased accuracy\nIncreased workload\n\n\nImproved data quality\nPossibly increased time use\n\n\nImproved chance of using the data for further projects\nDecreased chance of finishing on time\n\n\n\nAlternative: exclude atrophy as a biomarker. The HARNESS initiative as well as the FINESSE framework recommends exactly WMH, lacunes, microbleeds and atrophy as biomarkers.(Smith et al. 2019; Markus et al. 2022)"
  },
  {
    "objectID": "doc/irr.html#short-version",
    "href": "doc/irr.html#short-version",
    "title": "Inter rater reliability",
    "section": "",
    "text": "Agreement is acceptable for all but atrophy. See calculations in the end.\nMy suggestion will be to re-plan. Instead of retraining, I will assign two assessors to each subject. On disagreement, consensus will be sought.\nWith 8 assessors helping out, each will get to perform a mean of ~250 assessments\n\nPros and cons to the new approach\n\n\n\n\n\n\nPros\nCons\n\n\n\n\nIncreased accuracy\nIncreased workload\n\n\nImproved data quality\nPossibly increased time use\n\n\nImproved chance of using the data for further projects\nDecreased chance of finishing on time\n\n\n\nAlternative: exclude atrophy as a biomarker. The HARNESS initiative as well as the FINESSE framework recommends exactly WMH, lacunes, microbleeds and atrophy as biomarkers.(Smith et al. 2019; Markus et al. 2022)"
  },
  {
    "objectID": "doc/irr.html#litterature",
    "href": "doc/irr.html#litterature",
    "title": "Inter rater reliability",
    "section": "Litterature",
    "text": "Litterature\nStaals et al. (2014) reports Intraclass Correlation Coefficient of 0.68-0.92 depending on the biomarker. They use different aids to maximise the likelihood of agreement (reference pictures etc.).\nDepending on sources, Fleiss-Kappa or Intraclass Correlation Coefficient (ICC) are argued as the best meassure. Hallgren (2012) recommends using the ICC with multiple assessors and when scores are ordinal. Multiple performance measures are included.\nHere are a few discussions on the topic:\n\nresearchgate\ncookbook-for-r\nData\n\n\n\n\n\n\n\n\n\n\nsvd_user\nn\n\n\n\n\nABF\n52\n\n\nAGD\n52\n\n\nAMG\n1\n\n\nGA\n18\n\n\nJKM\n52\n\n\nKM√ò\n52\n\n\nMFH\n52\n\n\nNLP\n52\n\n\nRAB\n52\n\n\nSBV\n52\n\n\n\n\n\n\n\n\n\nInter-rater-disagreement examples\nExample of overall score differences\n\n\n\n\n\n\n\n\n\nsvd_user\nsvd_quality\nsvd_microbleed\nsvd_microbleed_location___1\nsvd_microbleed_location___2\nsvd_microbleed_location___3\nsvd_siderose\nsvd_lacunes\nsvd_wmh\nsvd_atrophy\n\n\n\n\nSBV\n2\n0\n0\n0\n0\n0\n0\n3\n1\n\n\nAGD\n1\n0\n0\n0\n0\n0\n0\n3\n2\n\n\nKM√ò\n2\n0\n0\n0\n0\n0\n0\n3\n1\n\n\nNLP\n2\n0\n0\n0\n0\n0\n0\n3\n2\n\n\nJKM\n2\n0\n0\n0\n0\n0\n0\n3\n2\n\n\nRAB\n2\n0\n0\n0\n0\n0\n0\n3\n1\n\n\nMFH\n1\n0\n0\n0\n0\n0\n0\n3\n1\n\n\nABF\n2\n0\n0\n0\n0\n0\n0\n3\n1\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nsvd_user\nmicrobleed\nlacunes\nwmh\natrophy\nscore\n\n\n\n\nSBV\n0\n0\n1\n0\n1\n\n\nAGD\n0\n0\n1\n1\n2\n\n\nKM√ò\n0\n0\n1\n0\n1\n\n\nNLP\n0\n0\n1\n1\n2\n\n\nJKM\n0\n0\n1\n1\n2\n\n\nRAB\n0\n0\n1\n0\n1\n\n\nMFH\n0\n0\n1\n0\n1\n\n\nABF\n0\n0\n1\n0\n1"
  },
  {
    "objectID": "doc/irr.html#calculations",
    "href": "doc/irr.html#calculations",
    "title": "Inter rater reliability",
    "section": "Calculations",
    "text": "Calculations\nOverall reliability measures on all variables\n\n\nWarning: Using an external vector in selections was deprecated in tidyselect 1.1.0.\n‚Ñπ Please use `all_of()` or `any_of()` instead.\n  # Was:\n  data %&gt;% select(.x)\n\n  # Now:\n  data %&gt;% select(all_of(.x))\n\nSee &lt;https://tidyselect.r-lib.org/reference/faq-external-vector.html&gt;.\n\n\n\n\n\n\n\n\n\nVariable\nAgreement\nKrippendorffs_Alpha\nFleiss_Kappa\nBrennan_Predigers_Kappa\nIntraclCorrCoef\n\n\n\n\nsvd_quality\n0.7884615\n0.3909154\n0.389447748\n0.7867959\n3.971007e-01\n\n\nsvd_microbleed\n0.6923077\n0.5344182\n0.533296331\n0.6923038\n8.384529e-01\n\n\nsvd_microbleed_location___1\n0.7884615\n0.6058272\n0.604877423\n0.7867959\n6.102045e-01\n\n\nsvd_microbleed_location___2\n0.8269231\n0.5509859\n0.549903896\n0.8255603\n5.551565e-01\n\n\nsvd_microbleed_location___3\n0.9230769\n0.4543851\n0.453070386\n0.9224712\n4.581498e-01\n\n\nsvd_siderose\n0.9795918\n0.0000000\n-0.002557545\n0.9794311\n-1.275022e-15\n\n\nsvd_lacunes\n0.4375000\n0.4987262\n0.497417440\n0.4374928\n7.205385e-01\n\n\nsvd_wmh\n0.1730769\n0.5336626\n0.532538933\n0.1730264\n7.904484e-01\n\n\nsvd_atrophy\n0.1960784\n0.2637533\n0.261944363\n0.1960294\n4.579298e-01\n\n\n\n\n\n\n\n\nReliability on simplified 0-4 scale.\n\n\n\n\n\n\n\n\n\nVariable\nAgreement\nKrippendorffs_Alpha\nFleiss_Kappa\nBrennan_Predigers_Kappa\nIntraclCorrCoef\n\n\n\n\nmicrobleed\n0.7307692\n0.6595911\n0.6587709\n0.7286493\n0.6635782\n\n\nlacunes\n0.6041667\n0.7007082\n0.6999267\n0.6010499\n0.7050209\n\n\nwmh\n0.6538462\n0.7193592\n0.7186830\n0.6511205\n0.7231512\n\n\natrophy\n0.7058824\n0.3095880\n0.3078916\n0.7035665\n0.3192449\n\n\nscore\n0.2553191\n0.5176905\n0.5164044\n0.2553096\n0.8003456"
  },
  {
    "objectID": "doc/irr.html#conclusion",
    "href": "doc/irr.html#conclusion",
    "title": "Inter rater reliability",
    "section": "Conclusion",
    "text": "Conclusion\nFor the simplified score, the Intraclass Correlations Coefficients for microbleed, lacunes, wmh, atrophy and score is 0.66, 0.71, 0.72, 0.32 and 0.8 respectively."
  },
  {
    "objectID": "doc/status.html",
    "href": "doc/status.html",
    "title": "Project status",
    "section": "",
    "text": "Below is an overview to get a project status and timeline."
  },
  {
    "objectID": "doc/status.html#annotation-progress",
    "href": "doc/status.html#annotation-progress",
    "title": "Project status",
    "section": "Annotation progress",
    "text": "Annotation progress\n\n\nCode\ncleaned |&gt;\n  dplyr::select(c(svd_user, svd_date)) |&gt;\n  (\\(x){\n    ds &lt;- x |&gt;\n      dplyr::count(svd_user) |&gt;\n      dplyr::mutate(label = glue::glue(\"{svd_user} (Total: {n})\"))\n    x |&gt; dplyr::mutate(svd_user = multi_replace(svd_user,\n      key = setNames(ds$svd_user, ds$label)\n    ))\n  })() |&gt;\n  dplyr::filter(svd_date&gt;\"2024-01-26\") |&gt; \n  #\n  # dplyr::count(svd_user,time_gr) |&gt;\n  # ggplot2::ggplot(ggplot2::aes(x=time_gr, y=n, fill=svd_user))+\n  # ggplot2::geom_col(position=\"dodge\")+\n  #\n  ggplot2::ggplot(ggplot2::aes(x = svd_date, fill = svd_user)) +\n  ggplot2::geom_bar() +\n  ggplot2::labs(title = \"Scoring by day after project launch\", fill = \"Assessor\") +\n  ggplot2::xlab(\"Date\") +\n  ggplot2::ylab(\"N\")\n\n\n\n\n\nLook out for the deadline rush\n\n\n\n\n\n\nCode\ncleaned |&gt;\n  dplyr::select(c(svd_user, svd_time)) |&gt;\n  dplyr::mutate(time_gr = time_cutter(svd_time, breaks = c(\n    \"00:00:00\",\n    \"08:00:00\",\n    \"12:00:00\",\n    \"16:00:00\",\n    \"20:00:00\",\n    \"23:59:00\"\n  ))) |&gt;\n  (\\(x){\n    ds &lt;- x |&gt;\n      dplyr::count(svd_user) |&gt;\n      dplyr::mutate(label = glue::glue(\"{svd_user} (Total: {n})\"))\n    x |&gt; dplyr::mutate(svd_user = multi_replace(svd_user,\n      key = setNames(ds$svd_user, ds$label)\n    ))\n  })() |&gt;\n  #\n  # dplyr::count(svd_user,time_gr) |&gt;\n  # ggplot2::ggplot(ggplot2::aes(x=time_gr, y=n, fill=svd_user))+\n  # ggplot2::geom_col(position=\"dodge\")+\n  #\n  ggplot2::ggplot(ggplot2::aes(x = time_gr, fill = svd_user)) +\n  ggplot2::geom_bar() +\n  ggplot2::labs(title = \"Scoring by time of day\", fill = \"Assessor\") +\n  ggplot2::xlab(\"Time interval\") +\n  ggplot2::ylab(\"N\")\n\n\nGeneric labels are used\n\n\n\n\n\nWhen is the free time?"
  },
  {
    "objectID": "doc/instrument.html",
    "href": "doc/instrument.html",
    "title": "Data capturing instrument",
    "section": "",
    "text": "Clinical data\nMinimal necessary clinical data for scoring are pooled and uploaded to a separate data base.\nThe scripts used are fairly trivial, but can serve as inspirational. The functions used can be found here.\nThe simple pipeline is as follows\n\n\nUsing REDCap\nAll clinical data capturing for this project is performed with REDCap.\nGet our most recent data dictionary here to inspect. Note that the text on a few fields are in Danish."
  }
]